PharmaCyte Biotech Inc (PMCB) — Tangible Net Worth Ratio
PharmaCyte Biotech Inc (PMCB) has a Tangible Net Worth Ratio of 96.1% as of January 2026. This metric is calculated by deducting intangible assets ($1.55 Million) from net assets ($39.40 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PMCB net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PharmaCyte Biotech Inc Tangible Net Worth Ratio (2006–2025)
This chart shows how PharmaCyte Biotech Inc's Tangible Net Worth Ratio has changed across 16 annual periods from 2006 to 2025. As of January 2026, the ratio stands at 96.1%, reflecting net assets of $39.40 Million with intangible assets of $1.55 Million USD. Also explore PharmaCyte Biotech Inc (PMCB) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for PharmaCyte Biotech Inc (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for PharmaCyte Biotech Inc from 2006 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see PharmaCyte Biotech Inc (PMCB) total market value.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.0% | $51.89 Million | $1.55 Million | $55.17 Million | ▲ +0.9 pp |
| 2024 | 96.1% | $39.51 Million | $1.55 Million | $59.90 Million | ▲ +1.0 pp |
| 2023 | 95.1% | $72.69 Million | $3.55 Million | $73.28 Million | ▼ -0.9 pp |
| 2022 | 96.1% | $89.92 Million | $3.55 Million | $90.62 Million | ▲ +49.2 pp |
| 2021 | 46.9% | $6.68 Million | $3.55 Million | $7.40 Million | ▲ +16.6 pp |
| 2020 | 30.3% | $5.09 Million | $3.55 Million | $6.17 Million | ▲ +0.7 pp |
| 2019 | 29.6% | $5.04 Million | $3.55 Million | $5.78 Million | ▼ -8.9 pp |
| 2018 | 38.5% | $5.77 Million | $3.55 Million | $6.41 Million | ▼ -17.6 pp |
| 2017 | 56.1% | $8.09 Million | $3.55 Million | $8.67 Million | ▲ +10.5 pp |
| 2016 | 45.6% | $6.52 Million | $3.55 Million | $7.16 Million | ▲ +5.4 pp |
| 2015 | 40.2% | $5.94 Million | $3.55 Million | $7.95 Million | ▼ -20.1 pp |
| 2014 | 60.3% | $8.94 Million | $3.55 Million | $9.32 Million | ▼ -18.2 pp |
| 2009 | 78.5% | $3.99 Million | $857.02K | $6.84 Million | ▼ -9.9 pp |
| 2008 | 88.4% | $7.44 Million | $863.40K | $7.62 Million | ▲ +8.5 pp |
| 2007 | 79.8% | $4.29 Million | $863.87K | $4.41 Million | ▼ -20.2 pp |
| 2006 | 100.0% | $4.41 Million | $0.00 | $5.14 Million | — |